Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03609177 · ClinicalTrials.gov registry record · NA
Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly
A NA study of Other Cancer, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 13,800
- Enrollment target
- 4
- Study locations
NCT03609177: Completed NA study of Other Cancer, sponsored by Dana-Farber Cancer Institute.
NCT03609177 is a NA study of Other Cancer that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 13,800 participants, above the 507-participant average among 5 other Other Cancer trials with a reported enrollment target (2622% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03609177, a NA study of Other Cancer, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 13,800 participants
- Enrollment target
- 4
- Study locations
Study Summary
In this research study, the investigators are working to help oncologists better serve patients by delivering more patient-centered, goal-concordant care that may improve health care delivery. \- It is expected that about 30,000 people will take part in this research study, 29,550 of these patients, the vast majority, will be included only for medical record review.
Primary Outcome
Any advance directive (e.g., living will, POLST, etc.) and changes of resuscitation orders or any indication in the EHR of a goals-of-care or advance care planning conversation
Conditions Studied
Interventions
- OTHER Clinician Communication Skills Training
- OTHER Advance Care Planning (ACP) Decisions Videos Decisions Aids
- OTHER Video Declarations (ViDec)
Study Locations (4)
Massachusetts
- Dana Farber Cancer Institute - Boston
Minnesota
- Mayo Clinic - Rochester
New York
- Northwell Health - New Hyde Park
North Carolina
- Duke Health - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,800 participants |
| Start Date | 2020-04-15 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
What the finished NCT03609177 record still lists
NCT03609177 is an interventional study that assigns participants to a tested intervention. Its 13,800 participants enrollment target places it among the larger protocols in the corpus, above the 507-participant average among 5 other Other Cancer trials with a reported enrollment target (2622% higher).
The record links to 1 condition, with Other Cancer appearing as the primary indexed condition, and to 3 interventions - of which Clinician Communication Skills Training is the first listed.
NCT03609177 reports a single indexed study location in Massachusetts, Minnesota, New York.
Frequently Asked Questions
What is clinical trial NCT03609177 about?
NCT03609177 is a clinical study titled "Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly". In this research study, the investigators are working to help oncologists better serve patients by delivering more patient-centered, goal-concordant care that may improve health care delivery. \- It is expected that about 30,000 people will take part in this research study, 29,550 of these patients...
What is the current status of trial NCT03609177?
This trial is currently completed. It is a NA study. The enrollment target is 13,800 participants. The study started on 2020-04-15. Estimated completion is 2024-09-30.
What conditions does trial NCT03609177 study?
This clinical trial studies the following conditions: Other Cancer.
What interventions are being tested in trial NCT03609177?
The interventions under investigation include: Clinician Communication Skills Training (OTHER), Advance Care Planning (ACP) Decisions Videos Decisions Aids (OTHER), Video Declarations (ViDec) (OTHER).
Who is sponsoring clinical trial NCT03609177?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03609177 being conducted?
This trial has 4 study locations across Massachusetts, Minnesota, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Other Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)
RECRUITING · NA
-
A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live CoActive Exercise Coaching and Personalized Digital Application on Cancer Survivors' Quality of Life
ACTIVE NOT RECRUITING · NA
-
A Geriatric Oncology Collaborative Care Intervention for Older Adults With Advanced Cancer
COMPLETED · NA
-
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
RECRUITING
-
Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT)
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06058767 · 13,764 participants · NA
Preschool Hearing Screening
- NCT05141396 · 13,400 participants · NA
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
- NCT05591066 · 14,400 participants · NA
The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now
- NCT05359016 · 14,600 participants · NA
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI